| Filed On | Filing |
|---|---|
| 07 Nov 2023 |
8-K/A: Other Events
On November 2, 2023, the Company received a $1,500,000 payment (the “Purchase Price”) from Fuji Pharma Co., Ltd. (“Fuji Pharma”), in accordance with the Exclusive Negotiation Agreement (the “Negotiation Agreement”) entered into by the Co... |
| 13 Dec 2018 | 8-K/A: Unregistered Sales of Equity Securities |
| 25 Feb 2016 | 8-K/A: Unregistered Sales of Equity Securities |
| 16 Oct 2012 | 8-K/A: Creation of a Direct Financial Obligation |
| 20 Dec 2011 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 12 Aug 2011 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 08 Jun 2011 | 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more |
Loading...
